Dr Alicia Granados MD,PhDPH | Head of Global Health Technology Assessment, POME- Global Medical Affairs
Genzyme

Dr Alicia Granados is since 2011 Head of Global Health Technology Assessment (HTA) Scientific Strategy at
Sanofi Genzyme, company based in Cambridge, Massachusetts.  The mission of her department is contributing to improve the effectiveness and efficiency of Sanofi Genzyme clinical research development plans and support Market Access strategies.

Researcher and associate professor at the School of Medicine of University of Barcelona until 2007, entrepreneur, international specialist in technology assessment and health care systems, was responsible for the creation and management of the Catalan Agency for Health Technology Assessment and Research ( CAHTAR ). Director and general manager of the Catalan Institute of Health (ICS ) and later Leader of the Health Evidence Network ( WHO - European Regional Office). Bioregió ( BIOCAT ) Ambassador  and of  the International Society for Health Technology Assessment ( HTAi ) of which she was founder. She has been president of Forética and has more than 60 scientific and health care policy papers published in international peer review journals.